CLOV - Company ID 0001801170
The table below shows CLOVER HEALTH INVESTMENTS, CORP. /DE's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B | $672.89M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | $257.33M | $70.24M | -$79.18M | - |
| R&D | - | - | - | - | - | - |
| SG&A |
CLOVER HEALTH INVESTMENTS, CORP. /DE reported annual revenue of $1.92B for fiscal year 2025. That is up 40.3% from $1.37B in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $462.27M (FY 2019) to $1.92B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $214.27M |
| $176.48M |
| $183.09M |
| $203.68M |
| $185.29M |
| $120.83M |
| Operating income | -$85.53M | -$45.75M | -$205.33M | -$286.66M | -$636.99M | -$92.71M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$85.55M | -$43.01M | -$213.36M | -$338.84M | -$587.76M | -$136.39M |
| EPS (diluted) | - | - | -$0.44 | -$0.71 | -$1.42 | -$1.54 |